In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection

Introduction: Increasing carbapenem resistance in Acinetobacter spp calls for the appraisal of alternative strategies in Acinetobacter spp infection therapy. This study aims at evaluating colistin-carbapenem combination against Acinetobacter spp using the checkerboard, Etest, and time-kill methods....

Full description

Saved in:
Bibliographic Details
Main Authors: Micheline Soudeiha, E Salem Sokhn, Ziad Daoud, Dolla Sarkis
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2018-02-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/10072
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849313580319506432
author Micheline Soudeiha
E Salem Sokhn
Ziad Daoud
Dolla Sarkis
author_facet Micheline Soudeiha
E Salem Sokhn
Ziad Daoud
Dolla Sarkis
author_sort Micheline Soudeiha
collection DOAJ
description Introduction: Increasing carbapenem resistance in Acinetobacter spp calls for the appraisal of alternative strategies in Acinetobacter spp infection therapy. This study aims at evaluating colistin-carbapenem combination against Acinetobacter spp using the checkerboard, Etest, and time-kill methods. Methodology: One hundred nonrepetitive Acinetobacter spp isolates were collected from patients admitted at the Saint-George-Hospital-University-Medical-Center over a one year period. The identification was performed using the API20NE and confirmed by the amplification of the blaOXA-51-like. Susceptibility to colistin, and carbapenems were determined using the Etest, microdilution methods and interpreted according to the CLSI, 2015. Detection of the carbapenemases was performed by PCR amplification method. Clonality was determined by the 3-Locus PCR-typing and ERIC-PCR methods. The synergistic potential of the combination was determined by calculating the Fractional-Inhibitory-Concentration-Index, which determines a synergistic, additive, indifferent or antagonistic effect. Results: In our study (84%) of the isolates were carbapenem resistant. Only one strain showed resistance to colistin. (99%) and (77%) of the Acinetobacter spp isolates harbored blaOXA-51-like and blaOXA-23-like respectively. (86.2%) of the A.baumannii isolates pertained to the International Clone II. An additive effect of the colistin-carbapenem combination was determined using the 3 methods. A decrease of 2.6 and 2.8 folds in the MIC of colistin was showed in colistin-meropenem and colistin-imipenem, respectively (p < 0.001). The Colistin-meropenem showed better effects when compared to colistin-imipenem (p < 0.05). Only a few isolates showed a synergistic effect in the time-kill assay. Conclusion: Our study showed that the decrease in the MIC of colistin following colistin-carbapenem combination might be a promising antimicrobial approach for treating carbapenem-resistant Acinetobacter spp.
format Article
id doaj-art-626a7ae53c79460bae7cda83d828dcc3
institution Kabale University
issn 1972-2680
language English
publishDate 2018-02-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-626a7ae53c79460bae7cda83d828dcc32025-08-20T03:52:43ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802018-02-011202.110.3855/jidc.10072In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infectionMicheline Soudeiha0E Salem Sokhn1Ziad Daoud2Dolla Sarkis3Rodolphe Merieux Laboratory, School of Pharmacy, Saint Joseph University, Beirut, LebanonBiomedical sciences department, Faculty of Medicine and Medical Sciences, University of Balamand, Koura, LebanonBiomedical sciences department, Faculty of Medicine and Medical Sciences, University of Balamand, Koura, LebanonRodolphe Merieux Laboratory, School of Pharmacy, Saint Joseph University, Beirut, Lebanon Introduction: Increasing carbapenem resistance in Acinetobacter spp calls for the appraisal of alternative strategies in Acinetobacter spp infection therapy. This study aims at evaluating colistin-carbapenem combination against Acinetobacter spp using the checkerboard, Etest, and time-kill methods. Methodology: One hundred nonrepetitive Acinetobacter spp isolates were collected from patients admitted at the Saint-George-Hospital-University-Medical-Center over a one year period. The identification was performed using the API20NE and confirmed by the amplification of the blaOXA-51-like. Susceptibility to colistin, and carbapenems were determined using the Etest, microdilution methods and interpreted according to the CLSI, 2015. Detection of the carbapenemases was performed by PCR amplification method. Clonality was determined by the 3-Locus PCR-typing and ERIC-PCR methods. The synergistic potential of the combination was determined by calculating the Fractional-Inhibitory-Concentration-Index, which determines a synergistic, additive, indifferent or antagonistic effect. Results: In our study (84%) of the isolates were carbapenem resistant. Only one strain showed resistance to colistin. (99%) and (77%) of the Acinetobacter spp isolates harbored blaOXA-51-like and blaOXA-23-like respectively. (86.2%) of the A.baumannii isolates pertained to the International Clone II. An additive effect of the colistin-carbapenem combination was determined using the 3 methods. A decrease of 2.6 and 2.8 folds in the MIC of colistin was showed in colistin-meropenem and colistin-imipenem, respectively (p < 0.001). The Colistin-meropenem showed better effects when compared to colistin-imipenem (p < 0.05). Only a few isolates showed a synergistic effect in the time-kill assay. Conclusion: Our study showed that the decrease in the MIC of colistin following colistin-carbapenem combination might be a promising antimicrobial approach for treating carbapenem-resistant Acinetobacter spp. https://jidc.org/index.php/journal/article/view/10072Acinetobacter sppadditive combinationICII
spellingShingle Micheline Soudeiha
E Salem Sokhn
Ziad Daoud
Dolla Sarkis
In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
Journal of Infection in Developing Countries
Acinetobacter spp
additive combination
ICII
title In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
title_full In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
title_fullStr In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
title_full_unstemmed In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
title_short In vitro analysis of colistin-carbapenem combination activity against Acinetobacter spp infection
title_sort in vitro analysis of colistin carbapenem combination activity against acinetobacter spp infection
topic Acinetobacter spp
additive combination
ICII
url https://jidc.org/index.php/journal/article/view/10072
work_keys_str_mv AT michelinesoudeiha invitroanalysisofcolistincarbapenemcombinationactivityagainstacinetobactersppinfection
AT esalemsokhn invitroanalysisofcolistincarbapenemcombinationactivityagainstacinetobactersppinfection
AT ziaddaoud invitroanalysisofcolistincarbapenemcombinationactivityagainstacinetobactersppinfection
AT dollasarkis invitroanalysisofcolistincarbapenemcombinationactivityagainstacinetobactersppinfection